Clostridium difficile infection (CDI). Recently, the significance of nosocomial transmission has been challenged by screening on admission studies and whole-genome sequencing, providing evidence for an endogenous source of C. difficile. We discontinued contact precautions for patients with CDI, except for patients infected with hypervirulent ribotypes or with stool incontinence, to determine the rate of transmission.
antibiotic stewardship program but has institutional guidelines on the use of antibiotics. Standard precautions with allocation of dedicated toilets for patients with CDI are implemented, except for patients diagnosed with CDI caused by hypervirulent strains (PCR ribotype 027 or 078), or patients with stool incontinence, which were placed under contact precautions. Standard precautions are promoted for any patient contact and include the proper use of hand hygiene (use of alcohol-based hand rub throughout the study period) and the use of personal protective equipment (ie, gloves, gowns, masks, eye protection) for procedures involving contact with body fluids [3] . Contact precautions include assignment to a single room and use of gloves and gowns at entrance. Routine cleaning procedures include the use of disinfectants without sporicidal activity in high-risk units, such as intensive care units and the bone marrow transplant unit, and the use of detergents on all other units. Rooms of patients placed under contact precaution are cleaned with a disinfectant with sporicidal activity in the case of C. difficile and a disinfectant without sporicidal activity for other pathogens. Contact patients exposed to patients infected with strains of ribotype 027 or 078 while identification of the ribotype was pending were also included. The study was approved by the local ethics committee as part of the quality assurance program, and informed consent was waived. The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines for reporting of observational studies were adhered to [6] .
All hospitalized patients diagnosed with CDI were considered index patients. CDI was defined using standard definitions [4] . All patients hospitalized in the same room as an index patient for at least 24 hours were defined as contact patients. Contact time was defined as the time both the index and the contact patient shared the same room together until performance of screening of the contact patient, which we aimed to perform prior to scheduled discharge.
The primary outcome was transmission of toxigenic C. difficile (defined as C. difficile with detection of toxin B alone and/ or toxin A) from an index to a contact patient, during hospitalization. Transmission was defined as possible if toxigenic C. difficile was detected in contacts, as probable if identical PCR ribotypes were identified in both the index and the contact patient, and as proven if next-generation sequencing revealed clonality of strains. The secondary outcome was development of CDI in contact patients either during hospitalization or during any inpatient or outpatient visits at our institution within 6 months of discharge. Contact patients were monitored for CDI during any readmission during the study period.
Surveillance for C. difficile Transmission
All stool specimens testing positive for C. difficile in our microbiology laboratory are reported to the infection control department by an electronic automatic daily monitor list. For each index case with CDI, the contacts were screened for toxigenic C. difficile by culturing rectal swabs (M40 Transystem Amies Agar gel, Copan Italia, Brescia, Italy).
Data Collection
Demographic, clinical, treatment, and microbiological data from both index and contact patients were extracted by electronic and paper medical record review including records on outpatient visits. Severe and recurrent CDI were defined using standard definitions [7, 8] .
Follow-up information regarding development of CDI within 6 months of discharge and during the entire study period was collected by review of all medical records and the electronic database of the microbiology laboratory at our institution.
Microbiology Methods
From 2004 to 2007, all stool samples were investigated by culture and by enzyme immunoassay (EIA) (C. DIFFICILE TOX A/B II, TechLab/Wampole, Blacksburg, Virginia) for detection of fecal toxin A/B. Toxin testing from cultured C. difficile isolates was conducted when fecal toxin was negative. In 2008, a 2-step approach with screening for C. difficile glutamate dehydrogenase (GDH) antigen (C.DIFF CHEK-60, TechLab/ Wampole) was introduced and only positive stools were further evaluated for C. difficile toxin by EIA or toxin testing from cultured C. difficile isolates if fecal toxin was negative [9] . From 2011 on, screening for GDH was followed by performance of PCR (Xpert C. difficile, Cepheid, Sunnyvale, California).
All rectal swabs were submitted to anaerobic culture. Toxin testing from culture was performed if C. difficile was detectable [10] .
Environmental samples were performed by swabbing surfaces with premoistened (sodium chloride 0.9%) cotton swabs prior to daily scheduled cleaning. Swabs were submitted to anaerobic culture. Eight places were examined in each room of consecutive patients with CDI: the telephone receiver, the patient's bell, the bed grip, the bed frame, the side table, the floor in front of the patient's bed, the toilet seat, and the floor in front of the toilet.
Anaerobic cultures were performed for all samples testing positive for toxigenic C. difficile, and all strains were collected.
From 2004 to 2011, PCR ribotyping to detect PCR ribotypes 027 and 078 was performed on all strains resistant to moxifloxacin [11, 12] . From 2011 on, PCR ribotyping was done for all isolates with a positive result for the presence of the binary toxin gene as determined by PCR (Xpert C. difficile).
PCR ribotyping was performed by high-resolution capillary gelbased electrophoresis [13] . The fragment profiles were compared to a standard set (http://www.ecdisnet.eu). The variation between restriction profiles was expressed as Dice coefficient correlation.
Sequencing was performed on an Illumina HiSeq 2000 platform, with a read length of 100 bases. Differences in single-nucleotide polymorphisms (SNPs) were interpreted as clonal between 0 and 2 and genetically related between 2 and 10 [1].
Statistical Analyses
Relative risks for transmission of toxigenic C. difficile were estimated using univariable Poisson regression with robust error variance [14] . The Pearson and deviance goodness-of-fit tests were performed to assess the fit of data to a Poisson distribution in the final regression model. All analyses were performed using Stata Statistical Software version 12.0 (StataCorp, College Station, Texas).
RESULTS
We identified 881 patients with toxigenic C. difficile. Among these, 750 fulfilled the definition of CDI, corresponding with an incidence of 2.88 CDI patients/10 000 patient-days. CDI patients without contacts were more commonly bone-marrow transplant recipients and leukopenic, and more likely to have died during hospital stay. CDI patients with contacts were more likely diagnosed with leukocytosis (Table 1) .
During their hospital stay, 493 contacts were exposed to 279 index cases. Active screening for toxigenic C. difficile by rectal swabs was performed for 91.5% of all contact patients (451/493). Forty-two contact patients were discharged before a rectal swab could be performed (Figure 1 ).
Toxigenic C. difficile was detected in 6.0% (27/451) of all contacts, indicating possible transmission. A large diversity of different ribotypes was identified among these 27 contact and their respective index patients (Table 2) . PCR ribotypes 078 and 027 were identified in 2 and none of the contact patients, respectively. Ribotyping identified probable transmission in 6 of 27 contacts, accounting for 1.3% (6/451). One of the transmissions occurred in a contact patient exposed to an index patient infected with a strain of ribotype 078 while results regarding strain identity were pending ( Table 2) . Next-generation sequencing could be performed for 4 of the 6 pairs with identical ribotypes, and confirmed transmission (clonality) in 2 pairs and genetical relatedness in the remaining 2 ( Table 2 and Supplementary Figure 1 ). In the remaining 2 pairs, next-generation sequencing could not be performed, as 2 of the strains could not be cultured after thawing. Contact patients with and without transmission of toxigenic C. difficile did not differ regarding baseline characteristics and exposures (Table 3) .
Of 493 contact patients, 5 patients developed CDI during their hospital stay. In 2 patients, the identical C. difficile ribotype as identified in their respective index patient was revealed as causative for CDI and, in both patients, probable transmission was found to have occurred prior to CDI onset. In the remaining 3 patients, of whom 2 were found to be colonized with different C. difficile ribotypes than their respective index patients, CDI was caused by different ribotypes than identified in their index patients (Figure 1) .
Follow-up information within 6 months of discharge was available for 63.4% (286/451) of all contact patients. Outpatient visits were recorded for 58.5% (264/451) of all contacts and an additional 22 (4.9%) patients were readmitted within 6 months. Among these, no additional cases of CDI were recorded.
Incidence of CDI increased at our institution during the study period from 2.8 per 10 000 patient-days in 2004 to 4.3 per 10 000 patient days in 2013 (P = .013). Absolute numbers of CDI cases and transmissions in relation to CDI incidence are depicted in Figure 2 .
During the study period, environmental samples were performed from the immediate surroundings of 16 consecutive index patients. Among these, toxigenic C. difficile was detected in 3 of 128 specimens (2.3%), all originating from the toilet seat.
DISCUSSION
We identified a low rate of transmission of toxigenic C. difficile during a 10-year study period in a tertiary academic care center only implementing standard precautions, except for patients infected with PCR ribotypes 027 or 078, or patients with stool incontinence. Our study challenges the routine use of contact precautions for patients with CDI in acute care hospitals with an effective infection control program, mostly 1-to 2-bed rooms, short contact time (5 days), and a low CDI incidence-potentially saving resources and improving patient care [15] [16] [17] . Despite the low number of transmissions identified in this cohort, it is noteworthy that among the 6 contact patients with probable transmission, 2 developed consecutive CDI.
Ribotyping may overestimate transmission events as compared to next-generation sequencing. In our study, transmission is unlikely in 2 index-contact pairs with identical ribotypes and 3 and 7 SNP differences as determined by sequencing.
Efforts to control further spread of C. difficile have so far largely focused on prevention of transmission in healthcare settings. Contact precautions, hand hygiene, environmental cleaning and disinfection, restriction of antimicrobials, and surveillance have been recommended to prevent person-to-person transmission [4] . While the use of gloves on entry to a room of a patient with CDI is supported by good evidence from one randomized controlled trial [18] , it must be noted that this study analyzed the use of disposable vinyl gloves by hospital personnel for all body substance contact (prior to the institution of universal body substance precautions)-a recommendation that is now part of the standard precautions for procedures involving contact with body fluids as outlined by the CDC guidelines [3] and which is established at our institution. The use of additional measures, such as the use of gowns, private rooms, and cohorting of patients with active CDI, is supported by moderate to poor evidence (B-III and C-III, respectively) and have been employed with varied success [4] . The use of gowns is mainly supported by detection of C. difficile on nursing uniforms [19] without any evidence for this being a relevant source of transmission. We were only able to identify toxigenic C. difficile on environmental samples taken from toilet seats, supporting our policy of assigning dedicated toilets to patients with CDI.
The low rate of transmission identified in our study is contrasted by an earlier report studying the acquisition and transmission of C. difficile on a general medical ward by serially culturing rectal swab specimens [20] . Of 399 patients with a negative C. difficile screening on hospital admission, 83 patients (21%) acquired C. difficile during hospitalization. Among these, 20 patients had identical immunoblot types as those of their respective roommates. Despite the presumably high rate of nosocomial acquisition reported in this study, exposure to roommates infected or colonized with C. difficile therefore accounted for acquisition of C. difficile in only one-quarter of all cases [20] . Of note, this finding led to the conclusion that the use of gloves and hand washing may be the most effective methods for limiting further nosocomial spread of C. difficile. The strict implementation of standard precautions, including the use of gloves for contact with any body fluids and allocation of dedicated toilets, may explain the lower rate of transmission identified in our study.
More recent data support that transmission through hospital-based contact with patients infected with C. difficile accounts for <25% of new CDI cases [21, 22] and that genetically diverse sources play a major part in C. difficile transmission [1] .
Incidence of CDI was lower at our institution than recently reported for Europe (mean, 7.0 cases of CDI per 10 000 patientbed days) [23] , but increased over the study period and this was not explained by nosocomial transmission. This is further supported by the large diversity of ribotypes of C. difficile detected in both patients and contacts. Our results add further credence to the growing body of evidence that diverse alternative sources may be the main driver of increasing CDI incidence-such as, possibly, the food chain [24] -a hypothesis supported by decreasing incidence rates of CDI in the United Kingdom by introducing interventions reducing susceptibility to disease (as exposure to antibiotics) [1, 25] , which may be by far the more important prevention strategy in patients colonized on hospital admission. Our increasing CDI rate, despite the lacking dominance of specific ribotypes suggesting nosocomial transmission, calls for active antibiotic stewardship interventions, which to date are lacking at our institution.
Our study has important limitations. Its conduction at a single center may impair generalizability. Our institution has a stringent infection control program reflected by high compliance with hand hygiene indications (>90%) [26] and low rates of infections with methicillin-resistant Staphylococcus aureus [27] . The use of antibiotics and the proportion of administered quinolones are lower in Swiss as compared to European acute care facilities (1.9 defined daily doses/1000 inhabitants/ day in Switzerland vs a mean of 2.0 defined daily doses/1000 inhabitants/day in other European countries, and approximately 10% of total antibiotic consumption in Switzerland vs up to 18% for other European countries; http://www.anresis. ch/index.php/anresisch-data-de.html and http://ecdc.europa. eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/database.aspx), further hampering generalizability. Incidence of CDI was low throughout the study period, albeit increasing over time, and no outbreaks were recorded. In addition, ribotypes 027 and 078 are not endemic at our institution. More than 90% of hospital beds are in 1-or 2-bed rooms and contact time was short (5 days). Our findings may therefore not apply to institutions with a high incidence of CDI, a predominance of ribotypes 027 and 078, less-effective infection control resources, a larger proportion of patient rooms with >2 beds, and longer hospital stays. Furthermore, our results are not generalizable to patients with CDI and stool incontinence. We cannot rule out that transmission was missed in some contact patients, as screening may have been performed too early after exposure. In addition, ward-wide transmission of C. difficile could have been missed, as patients cared for by the same staff as CDI patients, but not hospitalized in the same room, were not screened for C. difficile. Follow-up information was missing for 36.6% of contact patients. We therefore cannot rule out that these patients developed CDI after discharge caused by a strain transmitted during hospitalization and not detected by screening. However, patients with more specialized problems generally receive ongoing care in the hospital or in its associated outpatient clinics, for which we had access to all records and microbiological data, and it has been recently shown that our approach has the potential to capture 79% of the total burden of CDI [28] . In addition, patients not colonized with toxigenic C. difficile, which accounts for the vast majority of the exposed contact patients in our study, have a significantly lower risk for development of CDI [29] .
Due to the low number of transmissions detected in our study, it is underpowered to analyze risk factors for transmission of toxigenic C. difficile. Strains were not available for next-generation sequencing in 2 index-contact pairs. Screening for C. difficile was performed by analyzing rectal swabs rather than stool; however, this approach has been shown to be equally sensitive [10] . We further acknowledge that we did not study the consequences (by screening or capturing CDI rates) of not placing all patients with CDI under contact precautions regarding transmission of C. difficile to exposed healthcare workers.
As our detection rate of C. difficile from environmental samples was lower than previously reported [20, 30] , we cannot exclude this result being due to methodological issues known to occur when performing anaerobe cultures [31] .
In conclusion, discontinuing contact precautions did not lead to CDI outbreaks over a 10-year study period. The rate of transmission was low, challenging current guidelines for management of CDI. Contact isolation may lead to lower levels of care and additional costs. Such measures therefore should be based on strong scientific evidence, calling for reevaluation to balance risks of nosocomial transmission and risks for lower quality of care.
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